Cargando…
The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.
Eighty-two patients were randomly allocated to receive intravenous acyclovir 5 mg kg-1 t.d.s. for 23 days followed by oral acyclovir 800 mg 6-hourly for 6 months or matching placebos after allogeneic bone marrow transplantation. Herpes simplex and varicella zoster virus infections were significantly...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247066/ https://www.ncbi.nlm.nih.gov/pubmed/2539180 |
_version_ | 1782150902205906944 |
---|---|
author | Selby, P. J. Powles, R. L. Easton, D. Perren, T. J. Stolle, K. Jameson, B. Fiddian, A. P. Tryhorn, Y. Stern, H. |
author_facet | Selby, P. J. Powles, R. L. Easton, D. Perren, T. J. Stolle, K. Jameson, B. Fiddian, A. P. Tryhorn, Y. Stern, H. |
author_sort | Selby, P. J. |
collection | PubMed |
description | Eighty-two patients were randomly allocated to receive intravenous acyclovir 5 mg kg-1 t.d.s. for 23 days followed by oral acyclovir 800 mg 6-hourly for 6 months or matching placebos after allogeneic bone marrow transplantation. Herpes simplex and varicella zoster virus infections were significantly reduced during the period of administration of acyclovir. No reduction in cytomegalovirus infection was demonstrated. The drug was not toxic. |
format | Text |
id | pubmed-2247066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1989 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-22470662009-09-10 The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. Selby, P. J. Powles, R. L. Easton, D. Perren, T. J. Stolle, K. Jameson, B. Fiddian, A. P. Tryhorn, Y. Stern, H. Br J Cancer Research Article Eighty-two patients were randomly allocated to receive intravenous acyclovir 5 mg kg-1 t.d.s. for 23 days followed by oral acyclovir 800 mg 6-hourly for 6 months or matching placebos after allogeneic bone marrow transplantation. Herpes simplex and varicella zoster virus infections were significantly reduced during the period of administration of acyclovir. No reduction in cytomegalovirus infection was demonstrated. The drug was not toxic. Nature Publishing Group 1989-03 /pmc/articles/PMC2247066/ /pubmed/2539180 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Selby, P. J. Powles, R. L. Easton, D. Perren, T. J. Stolle, K. Jameson, B. Fiddian, A. P. Tryhorn, Y. Stern, H. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. |
title | The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. |
title_full | The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. |
title_fullStr | The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. |
title_full_unstemmed | The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. |
title_short | The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. |
title_sort | prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247066/ https://www.ncbi.nlm.nih.gov/pubmed/2539180 |
work_keys_str_mv | AT selbypj theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT powlesrl theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT eastond theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT perrentj theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT stollek theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT jamesonb theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT fiddianap theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT tryhorny theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT sternh theprophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT selbypj prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT powlesrl prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT eastond prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT perrentj prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT stollek prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT jamesonb prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT fiddianap prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT tryhorny prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation AT sternh prophylacticroleofintravenousandlongtermoralacyclovirafterallogeneicbonemarrowtransplantation |